Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ringe

Showing results (301-310 of 316) with videos related to

Pageof 32
Sort By:
Biochemistry|October 31, 1989
Effects of D-serine on bacterial D-amino acid transaminase: accumulation of an intermediate and inactivation of the enzymeA Martinez del Pozo, M A Pospischil, H Ueno, et al.
Current Medical Research and Opinion|January 17, 2013
Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)R Rizzoli, S Boonen, M-L Brandi, et al.
Science (New York, N.Y.)|March 4, 2000
The catalytic pathway of cytochrome p450cam at atomic resolutionI Schlichting, J Berendzen, K Chu, et al.
Bone|February 3, 2009
Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trialNeil Binkley, Johann D Ringe, John I Reed, et al.
Biochemistry|April 16, 1998
Substrate inhibition of D-amino acid transaminase and protection by salts and by reduced nicotinamide adenine dinucleotide: isolation and initial characterization of a pyridoxo intermediate related to inactivationP W van Ophem, S D Erickson, A Martinez del Pozo, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2013
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in menJ-M Kaufman, M Audran, G Bianchi, et al.
Biochemistry|December 24, 1996
The enolase superfamily: a general strategy for enzyme-catalyzed abstraction of the alpha-protons of carboxylic acidsP C Babbitt, M S Hasson, J E Wedekind, et al.
Bone|December 4, 2012
Treatment of osteoporosis in menJ-M Kaufman, J-Y Reginster, S Boonen, et al.
Climacteric : the Journal of the International Menopause Society|March 27, 2002
Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules. Department of Urogynaecology, King's College Hospital, LondonJ C Stevenson, U Gaspard, B Avouac, et al.
Calcified Tissue International|November 1, 1996
Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosisJ E Compston, M Audran, B Avouac, et al.
Pageof 32

Showing results (301-310 of 316) with videos related to

Sort By:
Pageof 32
Biochemistry|October 31, 1989
Effects of D-serine on bacterial D-amino acid transaminase: accumulation of an intermediate and inactivation of the enzymeA Martinez del Pozo, M A Pospischil, H Ueno, et al.
Current Medical Research and Opinion|January 17, 2013
Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)R Rizzoli, S Boonen, M-L Brandi, et al.
Science (New York, N.Y.)|March 4, 2000
The catalytic pathway of cytochrome p450cam at atomic resolutionI Schlichting, J Berendzen, K Chu, et al.
Bone|February 3, 2009
Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trialNeil Binkley, Johann D Ringe, John I Reed, et al.
Biochemistry|April 16, 1998
Substrate inhibition of D-amino acid transaminase and protection by salts and by reduced nicotinamide adenine dinucleotide: isolation and initial characterization of a pyridoxo intermediate related to inactivationP W van Ophem, S D Erickson, A Martinez del Pozo, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2013
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in menJ-M Kaufman, M Audran, G Bianchi, et al.
Biochemistry|December 24, 1996
The enolase superfamily: a general strategy for enzyme-catalyzed abstraction of the alpha-protons of carboxylic acidsP C Babbitt, M S Hasson, J E Wedekind, et al.
Bone|December 4, 2012
Treatment of osteoporosis in menJ-M Kaufman, J-Y Reginster, S Boonen, et al.
Climacteric : the Journal of the International Menopause Society|March 27, 2002
Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules. Department of Urogynaecology, King's College Hospital, LondonJ C Stevenson, U Gaspard, B Avouac, et al.
Calcified Tissue International|November 1, 1996
Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosisJ E Compston, M Audran, B Avouac, et al.
Pageof 32